Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference

Rhea-AI Summary

Eton Pharmaceuticals (Nasdaq: ETON), a pharmaceutical company specializing in rare disease treatments, announced its participation in the 2025 Wells Fargo Healthcare Conference. The company's executive team will be available for one-on-one meetings during the conference, which takes place from September 3-5, 2025 in Boston, MA.

Interested parties can schedule meetings through their Wells Fargo institutional sales representatives.

News Market Reaction – ETON

+2.16%

+2.16% Session close to close

In the Aug 20 session, ETON gained 2.16%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DEER PARK, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Company’s executive leadership team will host 1x1 meetings at the 2025 Wells Fargo Healthcare Conference being held September 3-5, 2025 in Boston, MA.

To schedule a 1x1 meeting with the Company, please contact your Wells Fargo institutional sales representative.

About Eton Pharmaceuticals

Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has eight commercial rare disease products: KHINDIVI™, INCRELEX^®, ALKINDI SPRINKLE^®, GALZIN^®, PKU GOLIKE^®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has five additional product candidates in late-stage development: ET-600, Amglidia^®, ET-700, ET-800 and ZENEO^® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: Eton Pharmaceuticals.

This press release was published by a CLEAR® Verified individual.

FAQ

When is Eton Pharmaceuticals (ETON) presenting at the Wells Fargo Healthcare Conference 2025?

Eton Pharmaceuticals will be participating in the conference from September 3-5, 2025 in Boston, MA, offering one-on-one meetings with the executive team.

How can investors meet with Eton Pharmaceuticals (ETON) management at the Wells Fargo conference?

Investors can schedule one-on-one meetings with Eton's management team through their Wells Fargo institutional sales representative.

Where is the 2025 Wells Fargo Healthcare Conference being held?

The 2025 Wells Fargo Healthcare Conference is being held in Boston, MA from September 3-5, 2025.

What is Eton Pharmaceuticals' (ETON) business focus?

Eton Pharmaceuticals is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.